Key Points in Fertility Preservation Treatment Strategies During Covid-19 Pandemic. An Update on Pharmacological Therapies

Abstract

The fertility preservation (FP) field has developed in the two decades and offers women the possibility to have genetic children at some point in life. Fertility preservation is urgent by definition, performed for social reasons or medical indications, such as impending gonadotoxic therapy or radical gynaecological surgery. One year after the pandemic was declared, the COVID-19 infection imposed several restrictions and limited access to health care for the infertile couple. Ovarian stimulation is a pharmacological treatment used to induce the development of ovarian follicles; FP guidelines provide different options for ovarian stimulation. We performed a systematic search on fertility preservation (FP) procedures during the COVID-19 pandemic using the keywords: FP, ovarian stimulation, assisted reproduction techniques (ART), and COVID-19. In order to update the different treatment strategies in ovarian stimulation on fertility preservation studied in the last ten years, we searched for randomized clinical trials (RCTs) focused on therapeutic agents used in current protocols, gonadotropins, gonadotropin releasing hormone (GnRH), clomiphene citrate (CC), letrozole, androgens, metformin, tamoxifen, glucocorticoids, aspirin, coenzyme Q10, and sildenafil. Fertility may be influenced by SARS-CoV-2 infection -especially in men; until more evidence confirms the effects on fertility, patients with COVID-19 positive should delay FP procedures if possible. Access to fertility conservation services decreased during the analysed period due to the medical services restrictions and the reorientation of medical resources on patients with COVID-19, without major changes in the current therapeutic protocols. In terms of pharmacotherapy in ovarian stimulation (OS) procedures, letrozole is first line therapy, superior to CC for OS. Similar ovulation and pregnancy rate can be obtained in letrozole -induced ovulation compared to gonadotropin protocol. Adjuvant therapies may be used for OS but lack proven efficacy. Further studies on adjuvant therapies and complementary support are needed, to ensure optimal condition in assisted reproductive interventions for fertility preservation, especially in gonadotoxic therapies. primă linie, superior clomifenului (CC) în OS. O ovulație și o rată de sarcină similară pot fi obținute în ovulația indusă de letrozol în comparație cu protocolul gonadotropinei. Terapiile adjuvante pot fi utilizate pentru OS, dar nu au o eficacitate dovedită. Sunt necesare studii suplimentare privind terapiile adjuvante și sprijinul complementar, pentru a asigura o stare optimă în intervențiile de reproducere asistată pentru conservarea fertilității, în special în terapiile gonadotoxice.

Study Regarding a New Extended-Release Calcium Ascorbate and Hesperidin Solid Oral Formulation

“…During the COVID pandemic, one of the defence shields was assuring high vitamin C levels in the body [31]. For long-term ascorbic acid use, high demand for good pharmacokinetic profiles and improved gastric tolerance was welcomed [32,33]. However, in vivo, bioavailability studies and digestibility studies may be developed to perform more accurate pharmacokinetic profiles [27].…”

Oncofertility and COVID-19: At the Crossroads between Two Time-Sensitive Fields

“…The standard of care during a pandemic for male patients is sperm banking with telephone triage [ 14 ], and for female patients is simple at-home ovarian stimulation protocols before embryo/oocyte cryopreservation prior to cancer treatment [ 58 , 104 ]. Additionally, operating protocols have been modified by the cessation of laparoscopic interventions due to the risk of transmitting aerosol infection among healthcare workers.…”

Evaluation of Knowledge on the Preventive Practice of Covid-19 Among Middle-Aged Adults in Saudi Arabia – A Cross-Sectional Questionnaire Based Study

“…The survey tool was prepared after an extensive literature review, with similar studies published both nationally and internationally [11,12,14,15,17]. The questionnaires for this study were clustered into three parts.…”

“…The disease knowledge, which comprises knowledge of the causative agent, transmission and symptoms, has a significant impact on this practice [14,15]. Numerous studies document that the gap or lack of knowledge about the diseases can increase the risk of infection transmission [14,15,17]. A previous study by Yasser and Thagfan reported that 96% of Saudi adults were aware of the clinical symptoms of COVID-19 and 57.9% were correctly identified that a stuffy nose and sneezing were less common in persons infected with the virus.…”